Researchers at the University of Turku, Finland, showed that the antibody treatment reactivates the immune defense in patients with advanced-stage cancer. The treatment alters the function of the body’s phagocytes and facilitates extensive activation of the immune system.
The InFLAMES Research Flagship (Innovation Ecosystem based on the Immune System) and its first selection process for postdoctoral researcher positions has been completed. Four postdoctoral researchers have been selected by the InFLAMES Executive Team. They will strengthen InFLAMES research groups of immunological research.
Although vaccination programmes against pertussis are very effective in Europe, new Finnish study shows that the disease is still very common among middle-aged adults in various European countries. At the same time, the results show that the disease is underdiagnosed as the annually reported figures are considerably lower than those discovered in the study.
The joint InFLAMES Flagship of the University of Turku and Åbo Akademi University has invited four top-level visiting professors to strengthen the initiative. The position of visiting professor at the University of Turku has been granted for the period of 1 April 2021–31 December 2024 to Professors Mark Ansel, Janne Lehtiö and Lawrence Steinman as well as to Director Teng-Leong Chew.
Docent Juha Laine has been appointed as Professor of Practice in Pharmacoeconomics and Dr. Timo Veromaa Professor of Practice in Drug Development. The appointments strengthen the operations of the InFLAMES Flagship, joint effort of the University of Turku and Åbo Akademi University, funded by the Academy of Finland. Both professors of practice have been offered part-time positions for the duration of the InFLAMES Flagship funding period.